SIREN : 329072011
BIOTECHNI is a French company founded 42 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in LA CIOTAT (13600), this company of category PME shows in 2021 a revenue of 7.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 7 789 800 € | 6 150 960 € | 6 826 003 € | 7 438 472 € | 6 899 509 € | 6 506 045 € | 5 680 987 € |
| Net income | 87 098 € | 70 033 € | 99 047 € | 56 227 € | -33 973 € | 22 531 € | 112 120 € | 9 788 € | 148 409 € | 8 091 € |
| EBITDA | N/C | N/C | N/C | 180 440 € | 74 054 € | 348 092 € | 701 844 € | 208 834 € | 256 779 € | 77 922 € |
| Net margin | N/C | N/C | N/C | 0.7% | -0.6% | 0.3% | 1.5% | 0.1% | 2.3% | 0.1% |
In 2024, BIOTECHNI generates positive net income of 87 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 8 k€ -> 87 k€.
87 098 €
The debt ratio (= Financial debt / Equity x 100) stands at 48%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
47.859%
45.399%
21.3%
In 2024, the debt ratio of BIOTECHNI (47.86) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIOTECHNI (45.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 200.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
200.11
In 2024, the liquidity ratio of BIOTECHNI (200.11) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 57 transactions of similar company sales
(all years),
the value of BIOTECHNI is estimated at
265 272 €
(range 61 646€ - 523 105€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOTECHNI with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of BIOTECHNI in 2021 is 7.8 M€.
Yes, BIOTECHNI generated a net profit of 87 k€ in 2024.
The headquarters of BIOTECHNI is located in LA CIOTAT (13600), in the department Bouches-du-Rhone.
The tax return of BIOTECHNI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOTECHNI operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.